Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Benserazide has been used:to inhibit dopa-decarboxylaseto induce dyskinesiato test on purified bacterial TDCs to assess the extent to which it could affect bacterial decarboxylasesas a peripheral dopa decarboxylase inhibitor to treat mice

Biochem/physiol Actions

Benserazide can block HK2 enzymatic activity in vitro. It is used along with levodopa to treat Parkinson′s disease.

Inhibitor of L-aromatic amino acid decarboxylase.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

General description

Benserazide is a peripheral decarboxylase inhibitor.